467 related articles for article (PubMed ID: 12447682)
1. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
3. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
4. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
Klebl FH; Olsen JE; Jain S; Doe WF
J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
[TBL] [Abstract][Full Text] [Related]
5. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
8. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
9. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
[TBL] [Abstract][Full Text] [Related]
12. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids.
Yang SK; Choi MS; Kim OH; Myung SJ; Jung HY; Hong WS; Kim JH; Min YI
Am J Gastroenterol; 2002 Jan; 97(1):126-32. PubMed ID: 11808935
[TBL] [Abstract][Full Text] [Related]
13. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
14. Bioactive IL-18 expression is up-regulated in Crohn's disease.
Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
[TBL] [Abstract][Full Text] [Related]
15. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
16. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
Stadnicki A; Mazurek U; Plewka D; Wilczok T
Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase.
Masuda H; Iwai S; Tanaka T; Hayakawa S
J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.
Krishna M; Woda B; Savas L; Baker S; Banner B
Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]